Keytruda, Merck
Pembrolizumab Newly Indicated to Treat Advanced Endometrial Carcinoma
The FDA approved pembrolizumab (Keytruda, Merck) for the treatment of patients with microsatellite instability?high ...
MARCH 23, 2022
Keytruda Gains Approval for Treatment of SCLC
The FDA granted accelerated approval to pembrolizumab (Keytruda, Merck) for the treatment of patients who have ...
JUNE 20, 2019
Keytruda Gains 2 New First-Line Indications: NSCLC and RCC
The FDA approved pembrolizumab (Keytruda, Merck) for the first-line treatment of patients with stage III/IV ...
APRIL 24, 2019
Keytruda Approved for Adjuvant Rx in Melanoma Patients With Lymph Node Involvement
The FDA approved pembrolizumab (Keytruda, Merck) for the adjuvant treatment of patients with melanoma with ...
FEBRUARY 22, 2019
Load more